Venture capital firm

Ampersand Capital Partners

A private equity firm focused on healthcare and life sciences companies

Visit Website Get introducedRequest an introduction Write a Review

TrustList summary

Ampersand Capital Partners is a private equity firm working in healthcare and life sciences. It partners with founders and leadership teams of its portfolio companies, aiming to let those leaders retain their positions while drawing on the firm's industry knowledge and resources. Its site features accounts from executives connected to companies including Tjoapack, NuvinkaDx, Resolian, Vibalogics, Brammer Bio, Adaptas Solutions, Nexcelom and Nexelis, describing their experience working with the firm. Ampersand states it has received a number of industry recognitions from third parties, noting these are the opinions of the organisations presenting them, that it may pay a fee to participate in some of them, and that they do not necessarily indicate future performance.

Summary written by TrustList from the business's own published information, Sep 2026.

Gallery

2 images - click to enlarge

Categories & features

Rankings

Ampersand Capital Partners is ranked on 5 TrustList rankings: #11 on 1, #23 on 1, #26 on 1, #29 on 1 and #50 on 1.

Every ranking orders its listings by their reviews, how complete the profile is and the Trust Score. Ampersand Capital Partners has no reviews yet and 3 of the 10 profile details we look for. Where no listing on a page has been reviewed, the order follows the profiles alone.

Venture capital firm · 5 rankings

#11of 35
Amsterdam
It is the only one of the 35 here listing biotech and one of 2 here listing private equity.
Of the 35 here, 7 also cover fintech and 4 also cover series a; 12 also work in London and 9 also work in New York City.
Behind AAC Capital Partners, ahead of Atalanta Therapeutics.
#23of 79
Biotech investors
It is the only one of the top 65 here listing private equity.
Of the top 65 here, 22 also cover healthtech and 17 also cover science; 14 also work in Boston and 13 also work in San Francisco.
Behind ALSA Ventures, ahead of Anthill Ventures.
#26of 59
Private equity firms
It is the only one of the top 57 here listing biotech.
Of the top 57 here, 20 also cover partners and 6 also cover growth stage; 5 also work in Chicago and 3 also work in United States.
Behind 1315 Capital, ahead of Beacon Equity Partners.
#29of 110
Boston
It is one of 3 here listing private equity and one of 11 here listing biotech.
Of the top 69 here, 11 also cover biotech and 10 also cover seed stage; 17 also work in Silicon Valley and 8 also work in Tokyo.
Behind Alumni Ventures Group, ahead of Atalanta Therapeutics.
#50of 244
London
It is one of 4 here listing private equity and one of 5 here listing biotech.
Of the top 64 here, 8 also cover private equity and 6 also cover SaaS; 8 also work in Hong Kong and 8 also work in Munich.
Behind Alumni Ventures Group.